Shree Ganesh BioTech India Ltd
BSE:539470
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Shree Ganesh BioTech India Ltd
Cash from Financing Activities
Shree Ganesh BioTech India Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shree Ganesh BioTech India Ltd
BSE:539470
|
Cash from Financing Activities
₹14.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
U
|
Universal Starch Chem Allied Ltd
BSE:524408
|
Cash from Financing Activities
-₹45.5m
|
CAGR 3-Years
37%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Kaveri Seed Company Ltd
NSE:KSCL
|
Cash from Financing Activities
-₹556.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Shree Ganesh BioTech India Ltd
Glance View
Shree Ganesh Biotech (India) Ltd. is a biotech firm, which engages in the production, processing, and marketing of hybrid seeds. The company is headquartered in Kolkata, West Bengal. The company went IPO on 2015-11-24. The firm is also involved in the business of tissue culture plant. The company is a provider of crop solutions to the farmer by supplying high yielding hybrid seeds and crop management, namely micronutrients and bioproducts. The firm is also engaged in research and development in the areas of superior breeding programs and biotechnology tools. The firm sells its products to the farmers in West Bengal, Odisha and Bihar.
See Also
What is Shree Ganesh BioTech India Ltd's Cash from Financing Activities?
Cash from Financing Activities
14.3m
INR
Based on the financial report for Dec 31, 2025, Shree Ganesh BioTech India Ltd's Cash from Financing Activities amounts to 14.3m INR.
